Hyderabad, Dec 5 (UNI) Dr. Reddy’s Laboratories Ltd announced today that it has launched Nystatin and Triamcinolone Acetonide Cream, USP, in the United States market and approved by the U.S. Food and Drug Administration (USFDA). Nystatin and Triamcinolone Acetonide Cream, USP is the generic equivanent of Nystatin and Triamcinolone Acetonide Cream, USP 100,000 units/g- 0.1% manufactured by Taro Pharmacueticals USA Inc, Hyderabad-based pharmaceutical company said in a statement here. The generic had U.S. sales of approximately $119 million MAT for the most recent twelve months ended in October 2016 according to IMS Health*. Dr. Reddy’s Nystatin and Triamcinolone Acetonide Cream, USP is available in tube sizes of 15g, 30g and 60g, the statement said. UNI KNR CS 1157